P312 efficacy in biologic failure and non-biologic-failure populations in a phase 3 study of ustekinumab in moderate–severe ulcerative colitis: UNIFI

Non ancora tradotto Non ancora tradotto
Categoria Primary study
GiornaleJ Crohns Colitis
Year 2019
Loading references information
Questo articolo non ha abstract
Epistemonikos ID: f9acfeff301fe2fa539b3cb79b107dbf0e4acb19
First added on: Dec 18, 2021